New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 11, 2013
05:36 EDTAMPEAmpio incorporates Luoxis Diagnostics, COO Josh Disbrow to be CEO if Luoxis
Ampio Pharmaceuticals announced the incorporation and initiation of operations of Luoxis Diagnostics, a subsidiary of Ampio that will initially be funded through a private placement, with Ampio maintaining approximately 80% ownership post financing. Josh Disbrow, Ampio's COO, will assume the role of CEO of Luoxis. Details about the private placement will follow in the near future.
News For AMPE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 11, 2016
07:42 EDTAMPEAmpio confirms sales agreement with Cantor Fitzgerald
Ampio Pharmaceuticals entered into a Controlled Equity Offering Sales Agreement with Cantor Fitzgerald. CEO Michael Macaluso stated "During our most recent conference call, we stated that we are not currently raising money and that we have enough money to get us through 2016 and into 2017 and still complete all of our current objectives and nothing has changed since that conference call. The "at-the-market" program may be used opportunistically and as a contingency facility to strengthen our position post-Ampion trial data."
07:36 EDTAMPEAmpio enters $20M controlled equity offering sales agreement with Cantor
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use